Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial
C. Y. C. Pak, John Poindexter, Khashayar Sakhaee(The University of Texas Southwestern Medical Center), Veronica Piziak(White Clinic), Beverley Adams‐Huet(Southwestern Medical Center)
Cited by 242
Related Papers
Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels
|Circulation|2001|732
Association of urinary pH with body weight in nephrolithiasis
|Kidney International|2004|404
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
|Journal of the American Society of Nephrology|2009|386
POTASSIUM-MAGNESIUM CITRATE IS AN EFFECTIVE PROPHYLAXIS AGAINST RECURRENT CALCIUM OXALATE NEPHROLITHIASIS
|The Journal of Urology|1997|371
Pathophysiologic basis for normouricosuric uric acid nephrolithiasis
|Kidney International|2002|346